CHRISTY ANDREWS: Open Payments
NPI 1942491865 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 59 payments from 14 companies in 2025. Trend: 2023 $4,656 · 2024 $207 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $240 |
| Collegium Pharmaceutical, Inc. | 10 | $190 |
| Boston Scientific Corporation | 3 | $185 |
| PFIZER INC. | 13 | $157 |
| Tonix Medicines, Inc. | 3 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $84 |
| Lundbeck LLC | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $43 |
Products named: NURTEC ODT, Intracept, UBRELVY, Belbuca, XTAMPZA, JOURNAVX, QULIPTA, VYEPTI.
Industry payments across VA — which companies pay providers there.
